Onycholysis secondary to multiple paclitaxel 1-hour infusions: possible role for its vehicle (Cremophor EL).
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects*; D019540:Area Under Curve; D001943:Breast Neoplasms / Q000188:drug therapy; D004334:Drug Administration Schedule; D005260:Female; D005990:Glycerol / Q000031:analogs & derivatives*; D006801:Humans; D007262:Infusions, Intravenous; D009260:Nail Diseases / Q000139:chemically induced*; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects*; D014677:Pharmaceutical Vehicles; D012997:Solvents / Q000008:administration & dosage / Q000009:adverse effects*; D013501:Surface-Active Agents / Q000008:administration & dosage / Q000009:adverse effects*
D000972:Antineoplastic Agents, Phytogenic; D014677:Pharmaceutical Vehicles; D012997:Solvents; D013501:Surface-Active Agents; C000515:cremophor EL; D017239:Paclitaxel; D005990:Glycerol